Kansas City Clinical Oncology Program

堪萨斯城临床肿瘤学项目

• 批准号: 9533502
• 负责人: Rakesh Gaur
• 金额: $ 58万
• 依托单位: NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2020-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9533502
• 关键词: Administrator; Adoption; Advanced Malignant Neoplasm; Advocate; Area; Behavioral; Behavioral Sciences; Cancer Control; Caring; Cities; Client satisfaction; Clinical Oncology; Clinical Trials; Communities; Community Participation; Conduct Clinical Trials; County; Development; Early Diagnosis; Elderly; Equilibrium; Evidence Based Medicine; Fostering; Funding; Gastroenterology; Genetic Counseling; Gynecologic Oncology; Health; Healthcare; Home environment; Hospitals; Image; Individual; Informatics; Internal Medicine; Kansas; Laboratories; Malignant Neoplasms; Measures; Medical; Medical Oncology; Minority; Minority Participation; Mission; Missouri; Monitor; National Cancer Institute; National Clinical Trials Network; Neighborhoods; Neurology; Nonprofit Organizations; Oncologist; Outcomes Research; Palliative Care; Participant; Pathology; Patient Participation; Patients; Pharmacogenomics; Physicians; Population; Population Heterogeneity; Prevention; Primary Health Care; Protocols documentation; Quality of life; Radiation Oncology; Radiology Specialty; Rehabilitation therapy; Reporting; Research; Research Personnel; Risk Factors; Safety; Science; Screening for cancer; Services; Southwest Oncology Group; Structure; Surgical Oncology; Symptoms; Technology; Travel; Underserved Population; Woman; base; cancer care; cancer prevention; cancer therapy; care delivery; cultural values; medical specialties; metropolitan; oncology program; outreach; personalized cancer therapy; programs; public health relevance; research and development; research study; screening; social; surveillance study; survivorship; trend; volunteer

DESCRIPTION (provided by applicant): The Kansas City Clinical Oncology Program (KCCOP) expects to transition to NCORP-KC. It is a very successful non-profit organization conducting clinical trials in cancer therapy, cancer symptom prevention. Quality of Life, and cancer control since 1983 with uninterrupted funding by the National Cancer Institute. The program is located in the Kansas City metropolitan area and serves the needs of both Kansas and Missouri residents spread over 16 counties and 2.5 million citizens. The program is comprised of seven component area hospitals and 52 investigators representing specialties well beyond medical, surgical, gynecologic, and radiation oncology. The other areas of expertise include outcomes research, internal medicine, healthcare administration, healthcare informatics, behavioral science, rehabilitation and survivorship, palliative care, neurology, gastroenterology, genetic counseling, pathology, cellular therapy, laboratory science, and radiology. The program has provided participation opportunities to over 4,200 patients and volunteers in cancer-related trials since its inception. Over the last five years, an average of 235 new individuals have participated per year. The program has maintained excellent quality of research as confirmed by patient satisfaction and reports from external audits. The program derives its cancer trials from SWOG, NRG, ALLIANCE, CTSU, MD Anderson, URCC, and SunCoast research bases of the National Cancer Institute. NCORP-KC wishes to thank its participants and extend its service by entering a new era of Cancer Care Delivery Research while continuing to conduct high quality trials in cancer therapy, cancer control, screening, imaging, and post-therapy surveillance. The program monitors trends and implements measures for continued improvement. It balances protecting patients, their safety, and health with providing the broadest possible access to trial activation and minority outreach participation with the help of a highly responsive and responsible support staff.

描述（由申请人提供）：堪萨斯城临床肿瘤学项目（KCCOP）预计将过渡到NCORP-KC。它是一个非常成功的非营利组织，在癌症治疗和癌症症状预防方面进行临床试验。 自1983年以来，在国家癌症研究所的不间断资助下， 该计划位于堪萨斯城大都市区，为分布在16个县和250万公民的堪萨斯和密苏里州居民提供服务。该计划由七个组成部分地区医院和52名研究人员组成，他们代表的专业远远超出了内科、外科、妇科和放射肿瘤学。其他专业领域包括成果研究，内科，医疗管理，医疗信息学，行为科学，康复和生存，姑息治疗，神经病学，胃肠病学，遗传咨询，病理学，细胞治疗，实验室科学和放射学。 自成立以来，该计划已为4，200多名患者和志愿者提供了参与癌症相关试验的机会。在过去五年中，平均每年有235名新的个人参加。该计划保持了良好的研究质量，这一点得到了患者满意度和外部审计报告的证实。该计划的癌症试验来自国家癌症研究所的SWOG、NRG、ALLIANCE、CTSU、MD安德森、URCC和SunCoast研究基地。 NCORP-KC希望通过进入癌症护理交付研究的新时代来感谢其参与者并扩展其服务，同时继续在癌症治疗，癌症控制，筛查，成像和治疗后监测方面进行高质量的试验。 该方案监测趋势，并采取措施不断改进。它在保护患者及其安全和健康与提供尽可能广泛的试验激活和少数人参与外展活动之间取得了平衡 在一个高度响应和负责任的支持人员的帮助下。